BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Heckler M, Michalski CW, Schaefle S, Kaiser J, Büchler MW, Hackert T. The Sendai and Fukuoka consensus criteria for the management of branch duct IPMN - A meta-analysis on their accuracy. Pancreatology 2017;17:255-62. [PMID: 28189431 DOI: 10.1016/j.pan.2017.01.011] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 7.4] [Reference Citation Analysis]
Number Citing Articles
1 Duconseil P, Adham M, Sauvanet A, Autret A, Périnel J, Chiche L, Mabrut JY, Tuech JJ, Mariette C, Turrini O. Fukuoka-Negative Branch-Duct IPMNs: When to Worry? A Study from the French Surgical Association (AFC). Ann Surg Oncol 2018;25:1017-25. [PMID: 29392508 DOI: 10.1245/s10434-017-6318-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
2 Zhou W, Xu Y, Rong Y, Wu W, Kuang T, Xin B, Zhu H, Lou W, Wang D. Validation of Sendai and Fukuoka consensus guidelines in predicting malignancy in patients with preoperatively diagnosed mucinous pancreatic cystic neoplasms. J Surg Oncol 2018;117:409-16. [DOI: 10.1002/jso.24882] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
3 Aronsson L, Andersson R, Ansari D. Intraductal papillary mucinous neoplasm of the pancreas – epidemiology, risk factors, diagnosis, and management. Scandinavian Journal of Gastroenterology 2017;52:803-15. [DOI: 10.1080/00365521.2017.1318948] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
4 Tanaka M, Heckler M, Liu B, Heger U, Hackert T, Michalski CW. Cytologic Analysis of Pancreatic Juice Increases Specificity of Detection of Malignant IPMN-A Systematic Review. Clin Gastroenterol Hepatol. 2019;. [PMID: 30630102 DOI: 10.1016/j.cgh.2018.12.034] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
5 Polk SL, Choi JW, McGettigan MJ, Rose T, Ahmed A, Kim J, Jiang K, Balagurunathan Y, Qi J, Farah PT, Rathi A, Permuth JB, Jeong D. Multiphase computed tomography radiomics of pancreatic intraductal papillary mucinous neoplasms to predict malignancy. World J Gastroenterol 2020; 26(24): 3458-3471 [PMID: 32655269 DOI: 10.3748/wjg.v26.i24.3458] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
6 Walsh RM, Perlmutter BC, Adsay V, Reid MD, Baker ME, Stevens T, Hue JJ, Hardacre JM, Shen GQ, Simon R, Aleassa EM, Augustin T, Eckhoff A, Allen PJ, Goh BKP. Advances in the management of pancreatic cystic neoplasms. Curr Probl Surg 2021;58:100879. [PMID: 34144739 DOI: 10.1016/j.cpsurg.2020.100879] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Hoda RS, Pitman MB. Pancreatic Cytology. Surgical Pathology Clinics 2018;11:563-88. [DOI: 10.1016/j.path.2018.04.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
8 Wu J, Wang Y, Li Z, Miao H. Accuracy of Fukuoka and American Gastroenterological Association Guidelines for Predicting Advanced Neoplasia in Pancreatic Cyst Neoplasm: A Meta-Analysis.Ann Surg Oncol. 2019;26:4522-4536. [PMID: 31617119 DOI: 10.1245/s10434-019-07921-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
9 D'Haese JG, Werner J. Surgery of Cystic Tumors of the Pancreas - Why, When, and How? Visc Med 2018;34:206-10. [PMID: 30182025 DOI: 10.1159/000489234] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
10 Hori Y, Ikeura T, Yamaguchi T, Yoshida K, Matsuzaki K, Ishida M, Satoi S, Okazaki K. Role of phosphorylated Smad3 signal components in intraductal papillary mucinous neoplasm of pancreas. Hepatobiliary Pancreat Dis Int 2020;19:581-9. [PMID: 32532597 DOI: 10.1016/j.hbpd.2020.05.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Penheiter AR, Deelchand DK, Kittelson E, Damgard SE, Murphy SJ, O'Brien DR, Bamlet WR, Passow MR, Smyrk TC, Couch FJ, Vasmatzis G, Port JD, Marjańska M, Carlson SK. Identification of a pyruvate-to-lactate signature in pancreatic intraductal papillary mucinous neoplasms. Pancreatology 2018;18:46-53. [PMID: 29170050 DOI: 10.1016/j.pan.2017.11.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
12 Kaiser J, Büchler MW, Hackert T. Response to: Enucleation: A treatment alternative for branch duct intraductal papillary mucinous neoplasms. Surgery 2017;162:197-9. [PMID: 28431801 DOI: 10.1016/j.surg.2017.03.006] [Reference Citation Analysis]
13 Salla C, Karvouni E, Nikas I, Ikonomakis A, Konstantinou P, Karoumpalis I, Sepsa A, Papaparaskeva K, Tsopanomichalou M, Georgiadou D, Kostopoulou A, Tsiotos G, Theocharis S, Sergentanis TN, Politi E. Imaging and Cytopathological Criteria Indicating Malignancy in Mucin-Producing Pancreatic Neoplasms: A Series of 68 Histopathologically Confirmed Cases. Pancreas 2018;47:1283-9. [PMID: 30308535 DOI: 10.1097/MPA.0000000000001182] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Hoshi H, Zaheer A, El Abiad RG, Maxwell JE, Chu LC, Gerke H, Chan CH. Management of pancreatic intraductal papillary mucinous neoplasm. Current Problems in Surgery 2018;55:126-52. [DOI: 10.1067/j.cpsurg.2018.03.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
15 Heckler M, Brieger L, Heger U, Pausch T, Tjaden C, Kaiser J, Tanaka M, Hackert T, Michalski CW. Predictive performance of factors associated with malignancy in intraductal papillary mucinous neoplasia of the pancreas. BJS Open 2018;2:13-24. [PMID: 29951625 DOI: 10.1002/bjs5.38] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
16 Hruban RH, Klimstra DS, Zamboni G, Klöppel G. A semicentennial of pancreatic pathology: the genetic revolution is here, but don't throw the baby out with the bath water! Hum Pathol 2020;95:99-112. [PMID: 31521627 DOI: 10.1016/j.humpath.2019.08.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
17 Bernard V, Semaan A, Huang J, San Lucas FA, Mulu FC, Stephens BM, Guerrero PA, Huang Y, Zhao J, Kamyabi N, Sen S, Scheet PA, Taniguchi CM, Kim MP, Tzeng CW, Katz MH, Singhi AD, Maitra A, Alvarez HA. Single-Cell Transcriptomics of Pancreatic Cancer Precursors Demonstrates Epithelial and Microenvironmental Heterogeneity as an Early Event in Neoplastic Progression. Clin Cancer Res 2019;25:2194-205. [PMID: 30385653 DOI: 10.1158/1078-0432.CCR-18-1955] [Cited by in Crossref: 98] [Cited by in F6Publishing: 75] [Article Influence: 24.5] [Reference Citation Analysis]
18 Kuwahara T, Hara K, Mizuno N, Okuno N, Matsumoto S, Obata M, Kurita Y, Koda H, Toriyama K, Onishi S, Ishihara M, Tanaka T, Tajika M, Niwa Y. Usefulness of Deep Learning Analysis for the Diagnosis of Malignancy in Intraductal Papillary Mucinous Neoplasms of the Pancreas. Clin Transl Gastroenterol. 2019;10:1-8. [PMID: 31117111 DOI: 10.14309/ctg.0000000000000045] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 12.0] [Reference Citation Analysis]
19 Nakahodo J, Fukumura Y, Saito T, Mitomi H, Saiura A, Fujisawa T, Ishii S, Isayama H, Kurahayashi I, Yao T. Radiological and Pathological Assessment of the 2017 Revised International Association of Pancreatology Consensus Guidelines for Intraductal Papillary Mucinous Neoplasm, With an Emphasis on the Gastric Pyloric Gland Type. Pancreas 2020;49:216-23. [PMID: 32011532 DOI: 10.1097/MPA.0000000000001487] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Aronsson L, Andersson R, Swahn F, Ansari D. Does next-generation sequencing of cyst fluid improve management of pancreatic cystic neoplasms? Scandinavian Journal of Gastroenterology 2017;52:1049-51. [DOI: 10.1080/00365521.2017.1349175] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
21 Hoda RS, Lu R, Arpin RN, Rosenbaum MW, Pitman MB. Risk of malignancy in pancreatic cysts with cytology of high-grade epithelial atypia. Cancer Cytopathology 2018;126:773-81. [DOI: 10.1002/cncy.22035] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
22 Amini N, Rezaee N, Habib JR, Blair A, Beckman RM, Manos L, Cameron JL, Hruban RH, Weiss MJ, Fishman EK, Zaheer A, Lafaro KJ, Burkhart RA, O'Broin Lennon AM, Burns WR, He J, Wolfgang CL. Minimal main pancreatic duct dilatation in small branch duct intraductal papillary mucinous neoplasms associated with high-grade dysplasia or invasive carcinoma. HPB (Oxford) 2021;23:468-74. [PMID: 32912834 DOI: 10.1016/j.hpb.2020.08.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Ei S, Mihaljevic AL, Kulu Y, Kaiser J, Hinz U, Büchler MW, Hackert T. Enucleation for benign or borderline tumors of the pancreas: comparing open and minimally invasive surgery. HPB (Oxford) 2021;23:921-6. [PMID: 33087306 DOI: 10.1016/j.hpb.2020.10.001] [Reference Citation Analysis]
24 Harrington KA, Williams TL, Lawrence SA, Chakraborty J, Al Efishat MA, Attiyeh MA, Askan G, Chou Y, Pulvirenti A, McIntyre CA, Gonen M, Basturk O, Balachandran VP, Kingham TP, D'Angelica MI, Jarnagin WR, Drebin JA, Do RK, Allen PJ, Simpson AL. Multimodal radiomics and cyst fluid inflammatory markers model to predict preoperative risk in intraductal papillary mucinous neoplasms. J Med Imaging (Bellingham) 2020;7:031507. [PMID: 32613028 DOI: 10.1117/1.JMI.7.3.031507] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
25 Pérez-Cuadrado-Robles E, Uribarri-González L, Borbath I, Vila JJ, López-López S, Deprez PH. Risk of advanced lesions in patients with branch-duct IPMN and relative indications for surgery according to European evidence-based guidelines. Dig Liver Dis 2019;51:882-6. [PMID: 30591368 DOI: 10.1016/j.dld.2018.11.028] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
26 Litchinko A, Kobayashi K, Halkic N. A retrospective study of histological outcome for IPMN after surgery in Lausanne, Switzerland: A case series. Ann Med Surg (Lond) 2020;60:110-4. [PMID: 33145018 DOI: 10.1016/j.amsu.2020.10.028] [Reference Citation Analysis]
27 Laquière A, Lagarde A, Napoléon B, Bourdariat R, Atkinson A, Donatelli G, Pol B, Lecomte L, Curel L, Urena-Campos R, Helbert T, Valantin V, Mithieux F, Buono JP, Grandval P, Olschwang S. Genomic profile concordance between pancreatic cyst fluid and neoplastic tissue. World J Gastroenterol 2019; 25(36): 5530-5542 [PMID: 31576098 DOI: 10.3748/wjg.v25.i36.5530] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Phan J, Raman Muthusamy V. Managing Incidental Pancreatic Cysts. Curr Gastroenterol Rep 2018;20. [DOI: 10.1007/s11894-018-0638-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Felix K, Honda K, Nagashima K, Kashiro A, Takeuchi K, Kobayashi T, Hinterkopf S, Gaida MM, Dang H, Brindl N, Kaiser J, Büchler MW, Strobel O. Noninvasive risk stratification of intraductal papillary mucinous neoplasia with malignant potential by serum apolipoprotein-A2-isoforms. Int J Cancer 2021. [PMID: 34778955 DOI: 10.1002/ijc.33875] [Reference Citation Analysis]
30 Dalal V, Carmicheal J, Dhaliwal A, Jain M, Kaur S, Batra SK. Radiomics in stratification of pancreatic cystic lesions: Machine learning in action. Cancer Lett 2020;469:228-37. [PMID: 31629933 DOI: 10.1016/j.canlet.2019.10.023] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 6.7] [Reference Citation Analysis]
31 Kolb JM, Argiriadi P, Lee K, Liu X, Bagiella E, Gupta S, Lucas AL, Kim MK, Kumta NA, Nagula S, Sarpel U, DiMaio CJ. Higher Growth Rate of Branch Duct Intraductal Papillary Mucinous Neoplasms Associates With Worrisome Features. Clin Gastroenterol Hepatol 2018;16:1481-7. [PMID: 29535058 DOI: 10.1016/j.cgh.2018.02.050] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
32 Al Efishat MA, Attiyeh MA, Eaton AA, Gönen M, Prosser D, Lokshin AE, Castillo CF, Lillemoe KD, Ferrone CR, Pergolini I, Mino-Kenudson M, Rezaee N, Dal Molin M, Weiss MJ, Cameron JL, Hruban RH, D'Angelica MI, Kingham TP, DeMatteo RP, Jarnagin WR, Wolfgang CL, Allen PJ. Multi-institutional Validation Study of Pancreatic Cyst Fluid Protein Analysis for Prediction of High-risk Intraductal Papillary Mucinous Neoplasms of the Pancreas. Ann Surg 2018;268:340-7. [PMID: 28700444 DOI: 10.1097/SLA.0000000000002421] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
33 Uribarri-González L, Pérez-Cuadrado-Robles E, López-López S, Lariño-Noia J, Martínez-Moneo E, Iglesias-García J, Fernández-Urién-Sanz I, Vila-Costas J. Development of a new risk score for invasive cancer in branch-duct intraductal papillary mucinous neoplasms according to morphological characterization by EUS. Endosc Ultrasound 2020;9:193-9. [PMID: 32584315 DOI: 10.4103/eus.eus_11_20] [Reference Citation Analysis]
34 Carmicheal J, Patel A, Dalal V, Atri P, Dhaliwal AS, Wittel UA, Malafa MP, Talmon G, Swanson BJ, Singh S, Jain M, Kaur S, Batra SK. Elevating pancreatic cystic lesion stratification: Current and future pancreatic cancer biomarker(s). Biochim Biophys Acta Rev Cancer 2020;1873:188318. [PMID: 31676330 DOI: 10.1016/j.bbcan.2019.188318] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
35 Kim M, Karadsheh Z, Levy A, Al-haddad MA. Management of Incidental Pancreatic Cystic Lesions: Integrating Novel Diagnostic and Prognostic Factors With Current Clinical Guidelines. Journal of Clinical Gastroenterology 2020;54:415-27. [DOI: 10.1097/mcg.0000000000001310] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 Krishna SG, Hart PA, Dewitt JM, Dimaio CJ, Kongkam P, Napoleon B, Othman MO, Yew Tan DM, Strobel SG, Stanich PP, Patel A, Luthra AK, Chan MQ, Blaszczak AM, Lee D, El-dika S, Mccarthy ST, Walker JP, Arnold CA, Porter K, Conwell DL. EUS-guided confocal laser endomicroscopy: prediction of dysplasia in intraductal papillary mucinous neoplasms (with video). Gastrointestinal Endoscopy 2020;91:551-563.e5. [DOI: 10.1016/j.gie.2019.09.014] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
37 Dbouk M, Brewer Gutierrez OI, Lennon AM, Chuidian M, Shin EJ, Kamel IR, Fishman EK, He J, Burkhart RA, Wolfgang CL, Hruban RH, Goggins MG, Canto MI. Guidelines on management of pancreatic cysts detected in high-risk individuals: An evaluation of the 2017 Fukuoka guidelines and the 2020 International Cancer of the Pancreas Screening (CAPS) consortium statements. Pancreatology 2021;21:613-21. [PMID: 33593706 DOI: 10.1016/j.pan.2021.01.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Eiterman A, Lahooti A, Krishna SG. Endosonographic diagnosis of advanced neoplasia in intraductal papillary mucinous neoplasms. World J Gastroenterol 2020; 26(23): 3201-3212 [PMID: 32684735 DOI: 10.3748/wjg.v26.i23.3201] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]